It's called a "waitlist" control group, and it's not intended to represent placebo. Or at least, it shouldn't be billed that way. It's not an ideal study design, but it's common enough that you could use it to compare one therapy to another based on their results vs a waitlist control. Placebo control for psychotherapy is tricky and more expensive, and can be hard to get the funding to do it properly.
